NDC 55513-840 – Aimovig

Erenumab 70 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC55513-840

Product details

Brand name
Aimovig
Generic name
Erenumab-aooe
Labeler
Amgen, Inc
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761077
Marketed since
May 22, 2018
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Aimovig →

Package NDC codes (1)

Package NDCDescriptionSince
55513-840-011 SYRINGE, GLASS in 1 CARTON (55513-840-01) / 1 mL in 1 SYRINGE, GLASSMay 22, 2018

Other Aimovig products